GoodRx HoldingsGDRX +0.53%60 Days Payable is 76.80 as of Mar. 2026, which is 41% below its 10-year median of 129.53. GuruFocus rates GDRX with a GF Score™ of 60/100 and a GF Value™ of $5.66 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 606 Healthcare Providers & Services companies, GoodRx Holdings ranks better than 73.93% on this metric.
The historical rank and industry rank for GoodRx Holdings's Days Payable or its related term are showing as below:
GDRX'
s Days Payable Range Over the Past 10 Years
Min: 98.71 Med: 129.53 Max: 435.46
Current: 117.14
During the past 8 years, GoodRx Holdings's highest Days Payable was 435.46. The lowest was 98.71. And the median was 129.53.
GDRX's Days Payable is ranked better than 73.93% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 58.205
vs GDRX: 117.14
GoodRx Holdings's Days Payable
declined
from Mar. 2025 (100.36) to Mar. 2026 (76.80).
It may suggest that GoodRx Holdingsaccelerated paying its suppliers.
GoodRx Holdings Days Payable Related Terms
GoodRx Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for GoodRx Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, GoodRx Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GoodRx Holdings Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GoodRx Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where GoodRx Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
GoodRx Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GoodRx Holdings (GDRX) has a Days Payable of 76.80 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on GoodRx Holdings and its competitors. This is 41% below median its historical median of 129.53. Over the past decade, GoodRx Holdings' Days Payable has ranged from 98.71 to 435.46. According to the industry distribution chart, GoodRx Holdings ranks #158 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 26.1%.
Is GoodRx Holdings' Days Payable too high?
GoodRx Holdings' current Days Payable of 76.80 is 41% below median its 10-year median of 129.53. Over the past 10 years, this metric has ranged from a low of 98.71 to a high of 435.46. The Healthcare Providers & Services industry median Days Payable is 58.21. GoodRx Holdings' value of 76.80 is 31.9% above this industry median. Based on the distribution chart, GoodRx Holdings ranks #158 out of 606 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, GoodRx Holdings has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does GoodRx Holdings' Days Payable compare to CERT and TALK?
According to the Healthcare Providers & Services industry distribution chart, GoodRx Holdings ranks #158 out of 606 companies for Days Payable. This puts GoodRx Holdings in the upper half of its industry. The industry median Days Payable is 58.21. GoodRx Holdings' value of 76.80 is 31.9% above this benchmark. Historically, GoodRx Holdings' own Days Payable has ranged from 98.71 to 435.46 over the past decade. While the company's 10-year median is 129.53 vs. the industry median of 58.21, GoodRx Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.21, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GoodRx Holdings's current Days Payable of 76.80 is 31.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on GoodRx Holdings and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GoodRx Holdings's current Days Payable is 76.80, which is 41% below median its own 10-year median of 129.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GoodRx Holdings stock overvalued right now?
Based on GuruFocus' analysis, GoodRx Holdings (GDRX) is currently considered Possible Value Trap. The stock's GF Value™ is $5.66, compared to a current price of $2.87 — trading 49.4% below its estimated fair value. The current Days Payable is 76.80, which is 41% below median its 10-year median of 129.53 and 31.9% above the Healthcare Providers & Services industry median of 58.21. GoodRx Holdings' overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For GoodRx Holdings (GDRX), the current Days Payable is 76.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GoodRx Holdings (GDRX) Overvalued in 2026?
Based on GuruFocus' analysis, GoodRx Holdings stock appears to be undervalued.
The current stock price of $2.87 is trading 49.4% below its estimated GF Value™ of $5.66.
GuruFocus considers GoodRx Holdings to be Possible Value Trap.
Key valuation signals for GDRX:
Days Payable: 76.80 (41% below median its 10-year median of 129.53)
GF Value™: $5.66 vs. price of $2.87 (49.4% below fair value)
Industry Position: 31.9% above the Healthcare Providers & Services median (#158 of 606)
No single metric tells the full story. See the GDRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
60GF Score
Get the complete analysis for GDRX
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GDRX has been successfully added to your 
